NeuroMetrix clears final FDA hurdle to market Sensus device

12/3/2012 | American City Business Journals

The FDA has cleared NeuroMetrix to market a disposable electrode that works with the firm's Sensus pain management device, which received clearance from the agency in August. The Sensus system employs electromagnetic nerve stimulation to treat leg pain in patients with diabetic peripheral neuropathy and is targeted for release before the end of 2012.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL